NO20001397L - Hepatitt B-virus-polypeptider - Google Patents

Hepatitt B-virus-polypeptider

Info

Publication number: NO20001397L
Authority: NO; Norway
Prior art keywords: hepatitis; fragment; virus polypeptides; hbv; polypeptide
Prior art date: 1997-09-19

Application number

NO20001397A

Other languages

English (en)

Norwegian (no)

Other versions

NO20001397D0 (no

Inventor

Steven Neville Chatfield

Original Assignee

Medeva Europ Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-09-19

Filing date

2000-03-17

Publication date

2000-05-05

2000-03-17 Application filed by Medeva Europ Ltd filed Critical Medeva Europ Ltd

2000-03-17 Publication of NO20001397D0 publication Critical patent/NO20001397D0/no

2000-05-05 Publication of NO20001397L publication Critical patent/NO20001397L/no

Links

241000700721 Hepatitis B virus Species 0.000 title abstract 3
229920001184 polypeptide Polymers 0.000 title abstract 3
108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
239000012634 fragment Substances 0.000 abstract 3
239000000203 mixture Substances 0.000 abstract 1
108010044241 tetanus toxin fragment C Proteins 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Virology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Engineering & Computer Science (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Veterinary Medicine (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20001397A 1997-09-19 2000-03-17 Hepatitt B-virus-polypeptider NO20001397L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9720033.1A GB9720033D0 (en)	1997-09-19	1997-09-19	Hepatitis B virus polypeptides
PCT/GB1998/002852 WO1999015671A1 (en)	1997-09-19	1998-09-21	Hepatitis b virus polypeptides

Publications (2)

Publication Number	Publication Date
NO20001397D0 NO20001397D0 (no)	2000-03-17
NO20001397L true NO20001397L (no)	2000-05-05

Family

ID=10819394

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20001397A NO20001397L (no)	1997-09-19	2000-03-17	Hepatitt B-virus-polypeptider

Country Status (15)

Country	Link
US (1)	US20040258709A1 (cs)
EP (1)	EP1015593B1 (cs)
JP (1)	JP2001517447A (cs)
KR (1)	KR100637282B1 (cs)
AT (1)	ATE241013T1 (cs)
AU (1)	AU751646B2 (cs)
CA (1)	CA2304255C (cs)
CZ (1)	CZ297131B6 (cs)
DE (1)	DE69814884T2 (cs)
ES (1)	ES2199460T3 (cs)
GB (1)	GB9720033D0 (cs)
HU (1)	HUP0003511A3 (cs)
NO (1)	NO20001397L (cs)
PL (1)	PL195242B1 (cs)
WO (1)	WO1999015671A1 (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0009470D0 (en)	2000-04-17	2000-06-07	Univ Southampton	Materials and methods relating to immune responses to fusion proteins
EP1281761A1 (en) *	2001-07-27	2003-02-05	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Hepatitis B virus pre-S1 derived synthetic polypeptides and their use thereof.
CA2530363C (en) *	2003-06-23	2013-05-07	Baxter International Inc.	Carrier proteins for vaccines
CN100537762C (zh) *	2004-06-24	2009-09-09	中国人民解放军军事医学科学院野战输血研究所	一种嵌合型病毒样颗粒疫苗载体蛋白及其制备方法与应用
CN111499722B (zh)	2012-11-12	2024-08-23	海德堡吕布莱希特-卡尔斯大学	用于治疗肝脏疾病和心血管疾病的脂肽
CN121646478A (zh) *	2023-06-23	2026-03-10	腾盛博药生物科技有限公司	慢性乙型肝炎的评估与治疗

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1341074C (en) *	1987-06-22	2000-08-08	Hans A. Thoma	Hbv surface antigen particles, prepared by recombinant dna processes, composed of different epitopes, selected from the pre-s and s-peptides as a new vaccine
EP0389983A3 (en) *	1989-03-31	1991-01-16	Abbott Laboratories	Monoclonal antibodies to pres2 and pres1 polypeptides of the hepatitis b viral envelope
WO1994001132A1 (en) *	1992-07-07	1994-01-20	Merck & Co., Inc.	VACCINE COMPRISING MIXED preS1+preS2+S AND CORE PARTICLE
ES2127829T3 (es) *	1992-07-31	1999-05-01	Medeva Holdings Bv	Expresion de proteinas recombinantes fusionadas en bacterias atenuadas.
EP0712442B1 (en) *	1993-07-30	2002-03-27	Medeva Holdings B.V.	Vaccine compositions
GB9401795D0 (en) *	1994-01-31	1994-03-23	Medeva Holdings Bv	Vaccines

1997
- 1997-09-19 GB GBGB9720033.1A patent/GB9720033D0/en not_active Ceased
1998
- 1998-09-21 PL PL98339366A patent/PL195242B1/pl not_active IP Right Cessation
- 1998-09-21 AT AT98944071T patent/ATE241013T1/de not_active IP Right Cessation
- 1998-09-21 CA CA002304255A patent/CA2304255C/en not_active Expired - Fee Related
- 1998-09-21 AU AU91744/98A patent/AU751646B2/en not_active Ceased
- 1998-09-21 KR KR1020007002945A patent/KR100637282B1/ko not_active Expired - Fee Related
- 1998-09-21 HU HU0003511A patent/HUP0003511A3/hu unknown
- 1998-09-21 ES ES98944071T patent/ES2199460T3/es not_active Expired - Lifetime
- 1998-09-21 DE DE69814884T patent/DE69814884T2/de not_active Expired - Fee Related
- 1998-09-21 EP EP98944071A patent/EP1015593B1/en not_active Expired - Lifetime
- 1998-09-21 CZ CZ20000978A patent/CZ297131B6/cs not_active IP Right Cessation
- 1998-09-21 JP JP2000512962A patent/JP2001517447A/ja active Pending
- 1998-09-21 WO PCT/GB1998/002852 patent/WO1999015671A1/en not_active Ceased
2000
- 2000-03-17 NO NO20001397A patent/NO20001397L/no not_active Application Discontinuation
2004
- 2004-07-15 US US10/892,018 patent/US20040258709A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20040258709A1 (en)	2004-12-23
CA2304255A1 (en)	1999-04-01
HUP0003511A3 (en)	2003-08-28
NO20001397D0 (no)	2000-03-17
PL339366A1 (en)	2000-12-18
KR20010024176A (ko)	2001-03-26
AU751646B2 (en)	2002-08-22
GB9720033D0 (en)	1997-11-19
JP2001517447A (ja)	2001-10-09
CZ2000978A3 (cs)	2001-01-17
CZ297131B6 (cs)	2006-09-13
PL195242B1 (pl)	2007-08-31
DE69814884T2 (de)	2004-03-11
EP1015593B1 (en)	2003-05-21
WO1999015671A1 (en)	1999-04-01
EP1015593A1 (en)	2000-07-05
KR100637282B1 (ko)	2006-10-24
HUP0003511A2 (hu)	2001-02-28
DE69814884D1 (de)	2003-06-26
AU9174498A (en)	1999-04-12
CA2304255C (en)	2009-07-07
ES2199460T3 (es)	2004-02-16
ATE241013T1 (de)	2003-06-15

Legal Events

Date	Code	Title	Description
2008-07-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
FI941199A0 (fi)	1994-03-14	Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
ATE236262T1 (de)	2003-04-15	Rekombinanter schweinepocken-virus
DE69824013D1 (de)	2004-06-24	Impfstoff gegen hpv
PT725824E (pt)	2003-08-29	Epitopos de celulas t humanas imunodominantes do virus da hepatite c
DE69531297D1 (de)	2003-08-21	Rekombinanter papillomavirus l1
DK1294893T3 (da)	2006-07-03	Modifikation af hepatitis B-kerneantigen
DE69111801D1 (de)	1995-09-07	Vakzin gegen hepatitis b.
ATE81357T1 (de)	1992-10-15	Rns des genoms des non-a, non-b-hepatitisvirus und antigenisches virales protein.
DK0698216T4 (da)	2009-06-15	Fremgangsmåder til typebestemmelse af hepatitis-C-virus og anvendte reagenser heri
FI910127A7 (fi)	1991-12-26	Ei-A-, ei-B-hepatiittiviruksen perimän cDNA ja antigeenipolypeptidi
MXPA03006971A (es)	2004-05-05	Tratamiento del virus de hepatitis b.
NO20001397D0 (no)	2000-03-17	Hepatitt B-virus-polypeptider
ATE473997T1 (de)	2010-07-15	Zur bildung von partikeln fähiges hbv-precore- protein
DE69123970D1 (de)	1997-02-13	Ehv-4 glykoprotein vazin
FR2815634B1 (fr)	2003-10-31	Anticorps monoclonaux diriges contre des virus de l'hepatite b
TR199501557A2 (tr)	1997-03-21	PreS2 peptid iceren hepatiti b viral yüzey antijenini aritma prosesi.
DE69922212D1 (de)	2004-12-30	Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
TR200201954T2 (tr)	2002-12-23	Viral hastalıklar için tıbbi maddeler.
DE122007000003I1 (de)	2007-05-24	Gegen mumps Impfstoff, der ein Virus des Jeryl-Lynn Stammes enthält
ATE409705T1 (de)	2008-10-15	Pre-s-protein von hepatitis-b-virus (hbv) als adjuvans und komponente eines hbv-impfstoffs
WO2001093804A3 (en)	2002-05-23	Hepatitis c virus conjugates
DE69130953D1 (de)	1999-04-08	Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie
GR3036125T3 (en)	2001-09-28	Recombinant proteins having the immunoreactivity of Hepatitis B virus e antigens (HBeAg), method for their production and their application in immunoassays and as vaccines.
AU4394101A (en)	2001-10-08	A nucleic acid construct encoding a processing component derived from the n-terminal region of the hepatitis virus ORF2, and an antigenic polypeptide